Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline plus rifampicin versus linezolid for MRSA complicated skin and skin structure infections
2014-001276-56Phase 4Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Complicated skin and skin structure infection (cSSSI) comparing Minocycline plus rifampicin with Linezolid (2 arms). Primary endpoint: Clinical cure at Test of Cure Day 14. Started Jun 2014; status: completed.
02
Drugs
minocyclinerifampicinlinezolid
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on 2014-001276-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001276-56.